12 May 2014
Tailwind Capital-backed drug maker VersaPharm is set to be bought by Akorn in a $440m all-cash deal.
Read full story
The outlook for infrastructure private equity and venture industry - from the latest AltAssets' LP-GP Forum
Private equity has delivered – yet most LPs are way below the allocation of top performers like Yale. Should more LPs be playing the long game and committing more to alternative asset classes?
AltAssets is registered as a trademark of Investor Networks Limited (06695690).Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJContent is © AltAssets 2000-2016